The American pharmaceutical giant Amgen $AMGN is once again demonstrating its commitment to global growth by investing approximately 200 million dollars in a new technology hub in southern India. This move reinforces the company’s ambition to strengthen its presence in the so-called "pharmacy of the world" and leverage innovative technologies for drug development. During the event on Monday, CEO Robert Bradway emphasized that additional significant investments are planned in the coming years.

New Technology Hub in India  

The inauguration of the hub in Hyderabad, the capital of Telangana, marks a pivotal milestone for Amgen. Presently, around 300 employees are working at the site, and the number is expected to reach approximately 2000 by the end of the year. This facility will focus on advancing artificial intelligence and data science applications in pharmaceutical research, thereby accelerating the process of creating new medical treatments.

Key Investment Highlights  

1. Primary Investment Directions  

• A bold start with 200 million dollars allocated for 2025  

• Plans for further substantial investments in the subsequent years  

2. Strengthening Presence in India  

• Creation of 1700 new jobs to bolster the workforce  

• Enhancing Amgen's market position in the global pharmaceutical industry

Advantages and Opportunities in the Pharmaceutical Sector  

- Extensive prospects for integrating artificial intelligence into drug development  

- Strengthened research and innovation through data science applications  

- Reinforcement of Amgen's international status amid global competition  

- Attraction of highly skilled professionals and the creation of a favorable business environment

Industry Events and Conferences  

This week, Hyderabad is also hosting the BioAsia conference, where leaders from top international pharmaceutical companies like Eli Lilly $LLY and Novartis $NOVN.SW, along with major Indian pharmaceutical giants, will take the stage. The event will serve as a dynamic forum for exchanging insights and discussing trends that are shaping the future of the industry.

Conclusion  

Amgen’s strategic decision to establish a new technology hub in India reflects the dynamic evolution of the pharmaceutical sector and the growing trend of integrating cutting-edge technologies into drug research and production. These investments are poised not only to strengthen the company's position on the global stage but also to open new avenues for innovation and medical advancement. In an increasingly competitive international arena, the creation of this hub represents a crucial step toward sustainable growth and industry leadership.